Taken together, miR-34a is an important regulator of leukemogenesis through different mechanisms including inhibition of CDK4, MYB, and SIRT1 expression, and/or suppression of B-Myb and E2F1 expression, leading to cell cycle arrest in cancer cells [38,39]. Here, E2F1 is linked to cancer.